The Trump administration's proposed reforms for Pharmacy Benefit Managers (PBMs) have been criticized for being less impactful than initially suggested. There are concerns that PBMs will find alternative methods to generate revenue, potentially undermining the intended regulatory changes. AI
RANK_REASON Article discusses policy implications and potential future actions of regulatory bodies and industry players, rather than a specific event.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →